Adagrasib

Adagrasib

Adagrasib

Min.Order / FOB Price:Get Latest Price

100 Gram

Negotiable

  • Min.Order :100 Gram
  • Purity: 99%
  • Payment Terms : L/C,T/T

Keywords

2-((S)-4-(7-(8-chloronaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido(3,4-d)pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile 2-Piperazineacetonitrile, 4-(7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-(((2S)-1-methyl-2-pyrrolidinyl)methoxy)pyrido(3,4-d)pyrimidin-4-yl)-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- adagrasib

Quick Details

  • Appearance:white powder
  • Application:Covalent inhibition of KRAS 12C with potential antitumor activity
  • PackAge:fiber can
  • ProductionCapacity:100|Kilogram|Year
  • Storage:store at 2-8℃
  • Transportation:air transport

Superiority:

The quality of our products is guaranteed and the price is low!

Details:

CAS number :2326521-71-3
English name :MRTX-849 English alias :Adagrasib; 2 - (4 - ((S) - 7 - (8 - chloronaphthalen - 1 - yl) - 2 - (((S) - 1 - methylpyrrolidin - 2 - yl) methoxy) - 5,6,7,8 - tetrahydropyrido pyrimidin - [3, 4 - d] 4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile; MRTX-849; Adagrasib/MRTX-849; MRTX849(Adagrasib); AzvudineImpurity23; MRTX849; MRTX-Chemicalbook849; MRTX849; 4 - [7-8 - CHLORO - 1 - (NAPHTHALENYL) - 5,6,7,8 - TETRAHYDRO - 2 - [[(2 s) - 1 - METHYL - 2 - PYRR; 4 - [2 - PIPERAZINEACETONITRILE, 7-8 - CHLORO - 1 - (NAPHTHALENYL) - 5,6,7,8 - TETRAHYDRO - 2 - [[(2 s) - 1 - METHYL - 2 - PYRR; 4 - [2 - PIPERAZINEACETONITRILE, 7-8 - CHLORO - 1 - (NAPHTHALENYL) - 5, Chemicalbook6, 7, 8 - TETRAHYDRO - 2 - [[(2 s) - 1 - METHYL - 2 - PYRR

Molecular formula:
C32H35ClFN7O2
Molecular weight:
604.12

Boiling point 860.2±75.0 °C(Predicted)
Density 1.295± 0.06g /cm3(Predicted)
Storage conditions -20°C
Soluble in DMSO:1.0(Max Conc.mg /mL); 1.7(Max Conc.mM)
Acidity coefficient (pKa)9.31±0.40(Predicted)
Morphological crystalline solid

MRTX-849 is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with KRASG12C mutation who have previously received at least one systemic therapy.
Biological activity

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View